<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-058308</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Paraneoplastic optic neuritis in an unknown small cell lung carcinoma defined by CRMP-5-IgG</dc:title>
<dc:description xml:lang="en">Case report: The case of a 64-year-old patient with    bilateral, progressive and painless diminution of    visual acuity is presented. Ophthalmologic evaluation    revealed optic neuritis and vitreous cells in    both eyes, at different stages. Suspecting a paraneoplastic    optic neuritis, the study of antibodies was    requested. This showed positivity to the marker    CRMP-5-IgG. After mediastinoscopy, a small cell    lung carcinoma was diagnosed.    Discussion: Autoantibody CRMP-5-IgG defines a    paraneoplastic entity of combined optic neuritis and    vitreous inflammatory cells. The serological positivity    avoids the vitreous biopsy and expedites the    search for cancer. In our case, it allowed the diagnosis    a previously unidentified tumor</dc:description>
<dc:creator>García-Ruiz-de-Morales, J. M</dc:creator>
<dc:creator>Toribio-García, J. A</dc:creator>
<dc:creator>Franco-Benito, M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Caso clínico: Se presenta el caso de un paciente de    64 años con disminución de agudeza visual bilateral,    progresiva e indolora. La exploración oftalmológica    reveló papilitis con vitritis en ambos ojos, en    distinto estadio. Con la sospecha de neuritis óptica    paraneoplásica se solicitó estudio de autoanticuerpos    que mostró positividad al marcador CRMP-5-    IgG. Tras realizar mediastinoscopia, se diagnosticó    un carcinoma microcítico pulmonar.    Discusión: El autoanticuerpo CRMP-5-IgG define    una entidad paraneoplásica consistente en neuritis    óptica con vitritis. La serología positiva evita la    biopsia vítrea y agiliza la búsqueda del cáncer. En    nuestro caso permitió el diagnóstico de un tumor    que era desconocido</dc:description>
<dc:source>Arch Soc Esp Oftalmol;82(12): 777-780, dic. 2007. ilus</dc:source>
<dc:identifier>ibc-058308</dc:identifier>
<dc:title xml:lang="es">Neuritis óptica paraneoplásica en carcinoma microcítico pulmonar desconocido definida por marcador CRMP-5-IgG</dc:title>
<dc:subject>^d27865^s22012</dc:subject>
<dc:subject>^d27729^s22012</dc:subject>
<dc:subject>^d27865^s22016</dc:subject>
<dc:subject>^d308^s22073</dc:subject>
<dc:subject>^d27729^s22016</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d8352^s22016</dc:subject>
<dc:subject>^d8649^s22045</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:type>article</dc:type>
<dc:date>200712</dc:date>
</metadata>
</record>
</ibecs-document>
